Free Trial

Teladoc Health (NYSE:TDOC) Trading Down 4.9%

Teladoc Health logo with Medical background

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) traded down 4.9% during trading on Monday . The company traded as low as $7.13 and last traded at $7.14. 3,244,902 shares traded hands during trading, a decline of 41% from the average session volume of 5,510,150 shares. The stock had previously closed at $7.51.

Analyst Ratings Changes

Several equities research analysts recently issued reports on TDOC shares. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Teladoc Health from $15.00 to $10.00 and set a "hold" rating for the company in a report on Friday, August 2nd. Truist Financial dropped their price objective on Teladoc Health from $15.00 to $10.00 and set a "hold" rating for the company in a report on Friday, August 2nd. Bank of America cut their target price on Teladoc Health from $16.50 to $13.50 and set a "neutral" rating on the stock in a research report on Tuesday, May 14th. JPMorgan Chase & Co. lowered their price target on Teladoc Health from $16.00 to $9.00 and set a "neutral" rating for the company in a research report on Monday, August 26th. Finally, Barclays dropped their price target on Teladoc Health from $20.00 to $10.00 and set an "overweight" rating for the company in a research note on Thursday, August 1st. Fourteen research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $12.44.

Get Our Latest Report on TDOC

Teladoc Health Stock Down 4.1 %

The firm's 50 day moving average price is $8.21 and its two-hundred day moving average price is $11.28. The firm has a market capitalization of $1.22 billion, a PE ratio of -5.11 and a beta of 0.90. The company has a quick ratio of 1.62, a current ratio of 1.66 and a debt-to-equity ratio of 0.66.


Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share for the quarter, beating analysts' consensus estimates of ($0.36) by $0.08. The company had revenue of $642.44 million during the quarter, compared to analysts' expectations of $649.34 million. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. As a group, research analysts forecast that Teladoc Health, Inc. will post -0.73 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In other news, insider Vidya Raman-Tangella sold 3,857 shares of the firm's stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $31,395.98. Following the completion of the sale, the insider now owns 33,667 shares of the company's stock, valued at $274,049.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, insider Vidya Raman-Tangella sold 3,857 shares of the stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $31,395.98. Following the transaction, the insider now owns 33,667 shares of the company's stock, valued at $274,049.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Laizer Kornwasser sold 10,879 shares of the business's stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $8.14, for a total value of $88,555.06. Following the completion of the sale, the chief executive officer now directly owns 99,929 shares of the company's stock, valued at $813,422.06. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 57,819 shares of company stock valued at $442,204. Insiders own 0.95% of the company's stock.

Hedge Funds Weigh In On Teladoc Health

Several large investors have recently added to or reduced their stakes in TDOC. ICA Group Wealth Management LLC bought a new stake in Teladoc Health during the fourth quarter valued at $28,000. Principal Securities Inc. bought a new stake in shares of Teladoc Health during the 4th quarter valued at about $45,000. Signaturefd LLC raised its stake in Teladoc Health by 148.7% during the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider's stock worth $28,000 after acquiring an additional 1,715 shares during the period. International Assets Investment Management LLC bought a new position in Teladoc Health in the second quarter worth about $29,000. Finally, SageView Advisory Group LLC acquired a new stake in Teladoc Health in the first quarter worth $48,000. 76.82% of the stock is currently owned by institutional investors.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

See Also

Should you invest $1,000 in Teladoc Health right now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Is Palantir Heading for a $50 Price Target?
Rate Cuts Fuel Volatility: How Long Could it Last?
SMCI Stock: Is a Rebound Coming?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines